Compare ARTNA & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARTNA | MOBI |
|---|---|---|
| Founded | 1905 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 383.0M |
| IPO Year | 1996 | 2026 |
| Metric | ARTNA | MOBI |
|---|---|---|
| Price | $32.96 | $8.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.75 |
| AVG Volume (30 Days) | 24.8K | ★ 175.3K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.82% | N/A |
| EPS Growth | ★ 11.62 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $112,941,000.00 | N/A |
| Revenue This Year | $3.59 | $71.88 |
| Revenue Next Year | $4.27 | $43.02 |
| P/E Ratio | $27.67 | ★ N/A |
| Revenue Growth | ★ 4.62 | N/A |
| 52 Week Low | $30.50 | $8.04 |
| 52 Week High | $36.98 | $15.19 |
| Indicator | ARTNA | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 37.68 | 40.64 |
| Support Level | $31.88 | $8.45 |
| Resistance Level | $33.75 | $9.85 |
| Average True Range (ATR) | 0.57 | 0.53 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 6.19 | 27.46 |
Artesian Resources Corp operates as a holding company based in the United States. Through its subsidiaries, it offers water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The Group distributes and sells water, including water for public and private fire protection, to residential, commercial, industrial, municipal, and utility customers. Additionally, it is involved in contract water and wastewater operations; offers wastewater services, and water, sewer, and internal Service Line Protection Plans. The Group operates its businesses mainly through one reportable segment, the Regulated Utility segment.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.